Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse event, Cough, Dyspnoea, Hyperhidrosis, Nausea
Clinical narrative: Exacerbation of viral infection; short of breath from short walk from office to car; Short of breath while seated; Trouble going up short flight of stairs; perspiring; trouble catching breath; generate phlegm; head between knees trying to catch breath; Wheezing at night with cough; Wheezing at night with cough; symptoms got worse; little bit of nausea; This spontaneous case was reported by a consumer and describes the occurrence of VIRAL INFECTION (Exacerbation of viral infection), DYSPNOEA (short of breath from short walk from office to car), DYSPNOEA (Short of breath while seated), DYSPNOEA (Trouble going up short flight of stairs) and HYPERHIDROSIS (perspiring) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pneumonia (possible double pneumonia) from 08-Jan-2021 to 03-Apr-2021. Concurrent medical conditions included Type II diabetes mellitus (Type II Diabetes A1 C 5.0  to 6.0 Controlled), Congestive heart failure (5% to 10% Cardiac Ejection Fraction) on 20-Jan-2021, Stent insertion NOS since 20-Mar-2021 and Echocardiogram (31.5% Cardiac Ejection Fraction - a siugnificant inprovement.) since 31-Mar-2021. Concomitant products included METFORMIN and INSULIN ASPART (NOVOLOG) from 05-Jan-2021 to an unknown date for Type II diabetes mellitus, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), MILK OF MAGNESIA, TICAGRELOR from 05-Mar-2021 to an unknown date, APIXABAN from 05-Mar-2021 to an unknown date, FAMOTIDINE (FAMOTIDINE ACID REDUCER) from 05-Mar-2021 to an unknown date, FUROSEMIDE, GABAPENTIN, LISINOPRIL, METOPROLOL, POTASSIUM, SPIRONOLACTONE, ROSUVASTATIN, MULTIVITAMIN & MINERAL, VITAMIN D3, CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID) and MELATONIN for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VIRAL INFECTION (Exacerbation of viral infection), DYSPNOEA (short of breath from short walk from office to car), DYSPNOEA (Short of breath while seated), DYSPNOEA (Trouble going up short flight of stairs), HYPERHIDROSIS (perspiring), DYSPNOEA (trouble catching breath), PRODUCTIVE COUGH (generate phlegm), DYSPNOEA (head between knees trying to catch breath), WHEEZING (Wheezing at night with cough), COUGH (Wheezing at night with cough), ADVERSE EVENT (symptoms got worse) and NAUSEA (little bit of nausea). At the time of the report, VIRAL INFECTION (Exacerbation of viral infection), DYSPNOEA (short of breath from short walk from office to car), DYSPNOEA (Short of breath while seated), DYSPNOEA (Trouble going up short flight of stairs), HYPERHIDROSIS (perspiring), DYSPNOEA (trouble catching breath), PRODUCTIVE COUGH (generate phlegm), DYSPNOEA (head between knees trying to catch breath), WHEEZING (Wheezing at night with cough), COUGH (Wheezing at night with cough), ADVERSE EVENT (symptoms got worse) and NAUSEA (little bit of nausea) outcome was unknown. Not Provided          Concomitant drugs included diuretics too.  No treatment information was reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Patient demographics,medical history and concomitant medications were added. Patient initial, gender, second dosing regimen added. Action taken updated to not applicable. Pulse rate deleted as event.